Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ALIGN: A Non-randomised Study Delivering Injectable Lenacapavir for HIV Prevention Within a Pre-exposure Prophylaxis (PrEP) Choice Context in Cape Town, South Africa.

NCT07390409 is registered in ClinicalTrials.gov with Desmond Tutu HIV Foundation as lead sponsor.

NCT NCT07390409
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07390409 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ALIGN: A Non-randomised Study Delivering Injectable Lenacapavir for HIV Prevention Within a Pre-exposure Prophylaxis (PrEP) Choice Context in Cape Town, South Africa.
Lead sponsor
Desmond Tutu HIV Foundation
Phase
Observational
Overall status
Not yet recruiting
Start date
January 29, 2026
Completion date
May 31, 2028
Enrollment
3,700 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv